News for Leap Therapeutics, Inc. (LPTX)

Leap Therapeutics (LPTX) will host a virtual KOL event on April 23, 2025, at 2:30 p.m. ET, focused on their lead drug candidate, sirexatamab (DKN-01). T

Leap Therapeutics (NASDAQ:LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ETCompany...

Leap Therapeutics (LPTX) stock extends losses as Baird downgrades citing disappointing trial data the company posted for its lead asset sirexatamab. Read more here.

U.S. stocks traded higher toward the end of trading, with the Dow Jones index rising over 150 points on Tuesday. The Dow traded up 0.34% to 44,865.65 while the...

Leap Therapeutics, Inc.'s DKN-01 trial results show mixed outcomes in cancer treatment, prompting potential future funding needs. Click for my LPTX stock update.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Tuesday. Following the market opening Tuesday, the Dow t...

Leap Therapeutics (LPTX) lost 63% after announcing it will not run a Phase 3 trial for its lead asset sirexatamab in gastric cancer. Read more here.

PR NewswireCAMBRIDGE, Mass., Jan. 6, 2025 CAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company foc

Leap Therapeutics focuses on developing DKN-01, a promising monoclonal antibody for solid tumors, with encouraging early trial data in GI cancers. Read more here.

PR NewswireCAMBRIDGE, Mass., Nov. 26, 2024 CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company f

H.C. Wainwright retains buy rating on Leap Therapeutics stock; cuts PT to $5.50

Leap Therapeutics is developing DKN-01, a drug with potential in multiple types of cancer. Read my earnings analysis of LPTX stock here.

/PRNewswire/ -- DelveInsight's Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...

Read Stock Analysts’ Price Target Changes for May 27th (ACHL, ADEVF, ANPCY, ATDRY, ATGSY, AVDL, BKKVF, BMEA, BNDSF, BNTGY) at ETF Daily News

Read Research Analysts’ Upgrades for May 19th (AAVMY, AAWW, AIT, AMOT, AMRN, AMZN, ATO, BCH, BCS, BECN) at ETF Daily News

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Short squeeze penny stocks to watch right now.

GuruFocus Article or News written by insider and the topic is about:

The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.45 A.M. EDT)..